Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Uveitis

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Uveitis in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Uveitis is a prevalent inflammatory eye disease that damages the vision of patients and even leads to blindness."1.72LY294002 attenuates inflammatory response in endotoxin-induced uveitis by downregulating JAK3 and inactivating the PI3K/Akt signaling. ( Chen, W; Li, D; Pu, L; Wu, G; Wu, X; Zhao, Q; Zhu, H, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wu, X1
Pu, L1
Chen, W1
Zhao, Q1
Wu, G1
Li, D1
Zhu, H1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Uveitis

ArticleYear
LY294002 attenuates inflammatory response in endotoxin-induced uveitis by downregulating JAK3 and inactivating the PI3K/Akt signaling.
    Immunopharmacology and immunotoxicology, 2022, Volume: 44, Issue:4

    Topics: Animals; Chromones; Cytokines; Endotoxins; Inflammation; Lipopolysaccharides; Morpholines; Phosphati

2022